data

Supermicro INNOVATE! EMEA 2025 – Discover the Latest Expanded AI Portfolio to Power Data Center and Edge Workloads

Just Released Systems Incorporate NVIDIA RTX Pro™ and NVIDIA HGX™ B300 GPUs, and NVIDIA GB300 NVL72 complete rack-scale solutionsEntire AI…

2 days ago

Huawei Unveils Fully Upgraded AI-Centric Xinghe Intelligent Network, Accelerating Intelligent Transformation Across Industries

SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- During HUAWEI CONNECT 2025, Huawei hosted the data communication innovation summit themed "Xinghe Intelligent…

2 days ago

Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…

2 days ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

2 days ago

Bravo Flowdex: How This Innovative Platform is Redefining AI Trading Read Bravo Flowdex Spain Report!

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction – What is Bravo Flowdex Bravo Flowdex is a…

3 days ago

Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!

New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to Net Rowdex Net Rowdex emerges in 2025 as…

3 days ago

Huawei and Industry Pioneers Unveil Over 30 Global Benchmark Showcases for Digital and Intelligent Transformation in the Data Communication Domain

SHANGHAI, Sept. 20, 2025 /PRNewswire/ -- During HUAWEI CONNECT 2025, Huawei and industry pioneers unveiled over 30 global benchmark showcases…

3 days ago

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

3 days ago

Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting

NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…

3 days ago

Huawei Cloud: Empowering Customers to Succeed in Global Markets Through Continuous Innovation

SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- At HUAWEI CONNECT 2025, Charles Yang, Senior Vice President of Huawei and President of…

4 days ago